PROMETIC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM U.S. FDA FOR ITS PLASMINOGEN REPLACEMENT THERAPY

August 29, 2017
Posted by: Fred Dumais
Posted In: Press Releases, Press Releases 2017
X